- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Therapeutic Effect of Propranolol in Mexican Patients with Infantile Hemangioma ; volume:3 ; number:1 ; day:21 ; month:12 ; year:2015 ; pages:25-31 ; date:3.2016
Drugs - real world outcomes ; 3, Heft 1 (21.12.2015), 25-31, 3.2016
- Creator
-
Castaneda, Saul
- Contributor
-
Garcia, Esbeydy
Cruz, Hermelinda De la
Ramirez, Oscar
Melendez, Samuel
Sanchez-Palacio, Jose
SpringerLink (Online service)
- DOI
-
10.1007/s40801-015-0052-3
- URN
-
urn:nbn:de:1111-2016033010694
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Castaneda, Saul
- Garcia, Esbeydy
- Cruz, Hermelinda De la
- Ramirez, Oscar
- Melendez, Samuel
- Sanchez-Palacio, Jose
- SpringerLink (Online service)
Other Objects (12)
Oral propranolol therapy in 23 infants with infantile hemangioma
Deep coma in a child treated with propranolol for infantile hemangioma
Nd:YAG 1064-nm laser for residual infantile hemangioma after propranolol treatment
Sleep behavior of infants with infantile hemangioma treated with propranolol—a cohort study
Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report
Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management
The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol
Circular RNA hsa_circ_0000915 promotes propranolol resistance of hemangioma stem cells in infantile haemangiomas
Correction to: Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents
Recurrent Epithelioid Hemangioma of the Bony Pelvis Responding to Propranolol
Oral propranolol therapy in 23 infants with infantile hemangioma
Deep coma in a child treated with propranolol for infantile hemangioma
Nd:YAG 1064-nm laser for residual infantile hemangioma after propranolol treatment
Sleep behavior of infants with infantile hemangioma treated with propranolol—a cohort study
Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report
Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management
The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol
Circular RNA hsa_circ_0000915 promotes propranolol resistance of hemangioma stem cells in infantile haemangiomas
Correction to: Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents
Recurrent Epithelioid Hemangioma of the Bony Pelvis Responding to Propranolol
Oral propranolol therapy in 23 infants with infantile hemangioma
Deep coma in a child treated with propranolol for infantile hemangioma
Nd:YAG 1064-nm laser for residual infantile hemangioma after propranolol treatment
Sleep behavior of infants with infantile hemangioma treated with propranolol—a cohort study
Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report
Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management
The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol
Circular RNA hsa_circ_0000915 promotes propranolol resistance of hemangioma stem cells in infantile haemangiomas
Correction to: Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents